Exosome Diagnostics and DxS Collaborate to Develop Blood Based Tests for Key Cancer Mutations
Exosome Diagnostics Inc and DxS Ltd today announced that they will collaborate on the development of blood based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR.
Read More